Koyfin Home > Directory > Health Care > Aeglea Biothera > Issuance of Common Stock

Aeglea Biothera Issuance of Common Stock Chart (AGLE)

Aeglea Biothera annual/quarterly Issuance of Common Stock from 2015 to 2020.
  • Aeglea Biothera Issuance of Common Stock for the quarter ending June 06, 2020 was $129m a 99.75% increase of 129m year over year
  • Aeglea Biothera Issuance of Common Stock for the last 12 months ending June 06, 2020 was $131m a 36.96% increase of 48m year over year
  • Aeglea Biothera Annual Issuance of Common Stock for 2019 was $66m a 13.20% increase of 9m from 2018
  • Aeglea Biothera Annual Issuance of Common Stock for 2018 was $57m a 78.60% increase of 45m from 2017
  • Aeglea Biothera Annual Issuance of Common Stock for 2017 was $12m a -304.24% decrease of -37m from 2016
Other Cash Flow Metrics:
  • Aeglea Biothera Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -3.43% increase of 0m year over year
  • Aeglea Biothera Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-6m a 25.45% decrease of -2m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE Issuance of Common Stock Data

06/2020$129m
03/2020$0m
12/2019$1m
09/2019$0m
03/2019$65m
12/2018$17m
09/2018$1m
06/2018$38m
03/2018$1m
12/2017$1m

Annual AGLE Issuance of Common Stock Data

2019$66m
2018$57m
2017$12m
2016$49m
2015$0m